Selected pre-operative factors which affect pancreaticoduodenectomy outcomes: a systematic review
Annals of Pancreatic Cancer · 2021-11 · 4 · 10-10
DOI: 10.21037/apc-21-15 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Annals of Pancreatic Cancer, 2021-11. Verfasst von Thomas B. Russell und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Pancreatic ductal adenocarcinoma (PDAC) affecting the head of the pancreas carries a dismal prognosis. For those with early disease, pancreaticoduodenectomy (PD) remains the only curative-intent treatment option. This is associated with considerable peri-operative morbidity and most patients develop disease recurrence. A greater understanding of the pre-operative factors which affect PD outcomes will improve patient selection, guide risk/benefit discussions and allow for pre-operative patient optimisation. We aimed to consolidate the recent literature on selected pre-operative factors and their impact on PD outcomes. The factors selected are currently being investigated by the Recurrence After Whipple’s (RAW) study.
Methods
A systematic search of the English literature (PubMed database) was carried out. Articles from May 2011 to May 2021 reporting on clinical studies with outcomes on PD for PDAC were included.
Results
One thousand, nine hundred and thirteen records were identified. Ninety-six were included in the final synthesis. Advanced age, as well as pre-existing cardiac and/or respiratory disease all increase peri-operative morbidity/mortality, but the impact of diabetes mellitus (DM) is less clear. Unhealthy body mass index (BMI) is associated with worse short-term outcomes and evidence is emerging which suggests sarcopenia and myosteatosis may affect short- and long-term outcomes. The impact of pre-operative biliary stenting (PBS) remains controversial and numerous laboratory/imaging findings can predict survival.
Discussion
Many of the factors investigated are non-modifiable. An appreciation for these allows clinicians to make an informed assessment of potential surgical candidates and can guide discussions surrounding risk and benefit. Important non-modifiable risk factors include advanced age and various laboratory/imaging findings. In this context, obesity can also be considered non-modifiable since obese patients are unlikely to significantly alter their body habitus prior to PD. Other factors, such as pre-existing cardiac disease, respiratory disease, and diabetes, are modifiable. Optimisation of these may reduce morbidity and increase the proportion of patients who complete adjuvant chemotherapy. The influence of many of the factors discussed are limited to single-centre retrospective analyses and may not include all confounding variables. Hence, a rigorous study is required.
Zitieren
APA
Russell, T. B., Labib, P. L., & Aroori, S. (2021). Selected pre-operative factors which affect pancreaticoduodenectomy outcomes: a systematic review. Annals of Pancreatic Cancer, 4, 10-10. https://doi.org/10.21037/apc-21-15
Vancouver
Russell TB, Labib PL, Aroori S. Selected pre-operative factors which affect pancreaticoduodenectomy outcomes: a systematic review. Annals of Pancreatic Cancer. 2021;4:10-10. doi:10.21037/apc-21-15
BibTeX
@article{Russell2021,
author = {Russell, Thomas B. and Labib, Peter L. and Aroori, Somaiah},
title = {Selected pre-operative factors which affect pancreaticoduodenectomy outcomes: a systematic review},
journal = {Annals of Pancreatic Cancer},
year = {2021},
volume = {4},
pages = {10--10},
doi = {10.21037/apc-21-15}
}
EUVIMED